GBG Forschungs GmbH is an independent academic research organisation specialising in clinical trials for breast cancer therapies. Founded in 2003, the institute operates across approximately 800 study centres in Germany, involving more than 1,000 physicians in its research network.
The institute's core activity is conducting clinical trials that investigate the efficacy of breast cancer treatments across all stages and types of the disease. Its participant database contains data on more than 70,000 breast cancer patients, with over 3,500 new patients enrolled annually. As an independent organisation, GBG Forschungs GmbH operates with neutrality in the healthcare and pharmaceutical research sector, grounded in its founding principle of advancing innovation through expertise and partnership.
